Abstract
Introduction and hypothesis
To assess the feasibility of objectively assessing pelvic floor hypertonicity (PFH) in women with interstitial cystitis/bladder pain syndrome (IC/BPS) using an intra-vaginal high-density surface electromyography (HD-sEMG) probe.
Methods
Seven female subjects (mean age 44 ± 13 years) with a prior diagnosis of IC/BPS were recruited. A full digital pelvic examination was administered to identify hypertonic muscles. Intra-vaginal HD-sEMG was acquired during rest. Root-mean-squared (RMS) amplitude during rest was calculated for each channel to define a hypertonicity index and hypertonic zone. Innervation zones (IZs) were identified from the bipolar mapping of decomposed HD-sEMG signals and summarized into an IZ distribution mapping.
Results
Of the seven subjects recruited, five had normal pelvic floor muscle tone and two exhibited hypertonicity upon muscle palpation. Subjects with PFH demonstrated a higher hypertonicity index (12.6 ± 3.5 vs. 4.5 ± 1.2) in sessions 1 and 2. The hypertonic zone defined by the 64-channel RMS mapping coincided with the digital pelvic examination findings. The corresponding IZs were localized for each motor unit. The hypertonicity indices between two consecutive sessions were well correlated (CC = 0.95).
Conclusions
This study represents the first effort to employ intra-vaginal HD-sEMG to assess PFH in women with IC/BPS. Our results demonstrate the feasibility of HD-sEMG to provide a quantitative diagnosis of PFH and the precise localization of hypertonic muscles and IZs. The proposed HD-sEMG-based techniques provide promising tools for clinical diagnosis and treatment of PFH, such as the personalized guidance of BoNT injections.
Similar content being viewed by others
Abbreviations
- PFH:
-
Pelvic floor hypertonicity
- IC/BPS:
-
Interstitial cystitis or bladder pain syndrome
- EMG:
-
Electromyography
- IZ:
-
Innervation zone
- MUAP:
-
Motor unit action potential
- HD-sEMG:
-
High-density surface electromyography
- BoNT:
-
Botulinum neurotoxin
- PFM:
-
Pelvic floor muscles
- RPC:
-
Right pubococcygeus
- RPR:
-
Right puborectalis
References
Bo K, Frawley HC, Haylen BT, Abramov Y, Almeida FG, Berghmans B, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J. 2017;28(2):191–213.
Peters KM, Carrico DJ, Kalinowski SE, Ibrahim IA, Diokno AC. Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology. 2007;70(1):16–8.
Butrick CW. Pathophysiology of pelvic floor hypertonic disorders. Obstetrics and Gynecology Clinics. 2009;36(3):699–705.
Weiss JM. Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol. 2001;166(6):2226–31.
Adelowo A, Hacker MR, Shapiro A, Modest AM, Elkadry E. Botulinum toxin type a (BOTOX) for refractory myofascial pelvic pain. Female pelvic medicine & reconstructive surgery. 2013;19(5):288.
Nesbitt-Hawes E, Won H, Jarvis S, Lyons S, Vancaillie T, Abbott J. Improvement in pelvic pain with botulinum toxin type A–single vs. repeat injections. Toxicon. 2013;63:83–7.
Lapatki B, Van Dijk J, Van de Warrenburg B, Zwarts M. Botulinum toxin has an increased effect when targeted toward the muscle’s endplate zone: a high-density surface EMG guided study. Clin Neurophysiol. 2011;122(8):1611–6.
Barbero M, Cescon C, Tettamanti A, Leggero V, Macmillan F, Coutts F, et al. Myofascial trigger points and innervation zone locations in upper trapezius muscles. BMC Musculoskelet Disord. 2013;14(1):179.
Thomson AJ, Jarvis SK, Lenart M, Abbott JA, Vancaillie TG. The use of botulinum toxin type a (BOTOX®) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles. BJOG Int J Obstet Gynaecol. 2005;112(2):247–9.
Nesbitt-Hawes E, Dietz H, Abbott J. Four-dimensional ultrasound guidance for pelvic floor botulinum toxin-a injection in chronic pelvic pain: a novel technique. Ultrasound Obstet Gynecol. 2018;51(3):396–400.
Morrissey D, El-Khawand D, Ginzburg N, Wehbe S, O’Hare P III, Whitmore K. Botulinum toxin a injections into pelvic floor muscles under electromyographic guidance for women with refractory high-tone pelvic floor dysfunction: a 6-month prospective pilot study. Female pelvic medicine & reconstructive surgery. 2015;21(5):277–82.
Peng Y, He J, Khavari R, Boone TB, Zhang Y. Functional mapping of the pelvic floor and sphincter muscles from high-density surface EMG recordings. Int Urogynecol J. 2016;27(11):1689–96.
Ning Y, Zhu X, Zhu S, Zhang Y. Surface EMG decomposition based onK-means clustering and convolution kernel compensation. IEEE journal of biomedical and health informatics. 2014;19(2):471–7.
Beretta Piccoli M, Rainoldi A, Heitz C, Wüthrich M, Boccia G, Tomasoni E, et al. Innervation zone locations in 43 superficial muscles: toward a standardization of electrode positioning. Muscle Nerve. 2014;49(3):413–21.
Zhang C, Dias N, He J, Zhou P, Li S, Zhang Y (2019) Global innervation zone identification with high-density surface electromyography. IEEE Trans Biomed Eng.
Grape HH, Dedering Å, Jonasson AF. Retest reliability of surface electromyography on the pelvic floor muscles. Neurourology and Urodynamics: Official Journal of the International Continence Society. 2009;28(5):395–9.
Enck P, Franz H, Azpiroz F, Fernandez-Fraga X, Hinninghofen H, Kaske-Bretag K, et al. Innervation zones of the external anal sphincter in healthy male and female subjects. Digestion. 2004;69(2):123–30.
Dias N, Li X, Zhang C, Zhang Y. Innervation asymmetry of the external anal sphincter in aging characterized from high-density intra-rectal surface EMG recordings. Neurourol Urodyn. 2018;37(8):2544–50.
Saitou K, Masuda T, Michikami D, Kojima R, Okada M. Innervation zones of the upper and lower limb muscles estimated by using multichannel surface EMG. J Hum Ergol. 2000;29(1–2):35–52.
Yang EJ, D-w R, Yoo JK, Park ES. Accuracy of manual needle placement for gastrocnemius muscle in children with cerebral palsy checked against ultrasonography. Arch Phys Med Rehabil. 2009;90(5):741–4.
Walter U, Dressler D. Ultrasound-guided botulinum toxin injections in neurology: technique, indications and future perspectives. Expert Rev Neurother. 2014;14(8):923–36.
Dessie SG, Von Bargen E, Hacker MR, Haviland MJ, Elkadry E. A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin a trigger point injections for myofascial pelvic pain. Am J Obstet Gynecol. 2019;221(5):517. e511–9.
Schnitzler A, Roche N, Denormandie P, Lautridou C, Parratte B, Genet F. Manual needle placement: accuracy of botulinum toxin a injections. Muscle Nerve. 2012;46(4):531–4.
Voorham-van der Zalm PJ, Voorham JC, van den Bos TW, Ouwerkerk TJ, Putter H, Wasser MN, et al. Reliability and differentiation of pelvic floor muscle electromyography measurements in healthy volunteers using a new device: the multiple array probe Leiden (MAPLe). Neurourol Urodyn. 2013;32(4):341–8.
Funding
This study received funding support from the SUFU Foundation, NIH DK113525 and AG053778.
Author information
Authors and Affiliations
Contributions
ND: Data collection, Data analysis, Result interpretation, Manuscript writing/editing; CZ: Data collection, Data analysis, Manuscript writing/editing; CS: Project development, Data collection, Result interpretation, Manuscript writing/editing; HL: Result interpretation, Manuscript writing/editing; YZ: Project development, Data collection, Data analysis, Result interpretation, Manuscript writing/editing.
Corresponding author
Ethics declarations
Ethics approval
The study protocol was reviewed and approved by the Institutional Review Board of The University of Houston and Baylor College of Medicine. All subjects gave written informed consent.
Conflict of interest
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dias, N., Zhang, C., Smith, C.P. et al. High-density surface electromyographic assessment of pelvic floor hypertonicity in IC/BPS patients: a pilot study. Int Urogynecol J 32, 1221–1228 (2021). https://doi.org/10.1007/s00192-020-04467-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-020-04467-2